Mn<sub>3</sub>O<sub>4</sub> Nanocrystal-Induced Eryptosis Features Ca<sup>2+</sup> Overload, ROS and RNS Accumulation, Calpain Activation, Recruitment of Caspases, and Changes in the Lipid Order of Cell Membranes.
Ontology highlight
ABSTRACT: Accumulating evidence suggests that manganese oxide nanoparticles (NPs) show multiple enzyme-mimicking antioxidant activities, which supports their potential in redox-targeting therapeutic strategies for diseases with impaired redox signaling. However, the systemic administration of any NP requires thorough hemocompatibility testing. In this study, we assessed the hemocompatibility of synthesized Mn3O4 NPs, identifying their ability to induce spontaneous hemolysis and eryptosis or impair osmotic fragility. Concentrations of up to 20 mg/L were found to be safe for erythrocytes. Eryptosis assays were shown to be more sensitive than hemolysis and osmotic fragility as markers of hemocompatibility for Mn3O4 NP testing. Flow cytometry- and confocal mic
SUBMITTER: Kot Y
PROVIDER: S-EPMC11989249 | biostudies-literature | 2025 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA